Brief: CASI Pharmaceuticals Announces Third Quarter 2021 Financial Results
12/11/2021 12:26
Nov 12 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2021
FINANCIAL
RESULTS
* Q3 REVENUE $8.1 MILLION
* QTRLY NET LOSS PER SHARE $0.07
* Q3 EARNINGS PER SHARE VIEW $-0.06, REVENUE VIEW $7.5
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nPnqCPWda
Further company coverage: CASI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary